R Squared Ltd purchased a new stake in Credicorp Ltd. (NYSE:BAP – Free Report) in the 4th quarter, HoldingsChannel reports. The fund purchased 940 shares of the bank’s stock, valued at approximately $172,000.
Other institutional investors have also recently made changes to their positions in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Credicorp by 782.7% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,326,947 shares of the bank’s stock valued at $240,138,000 after buying an additional 1,176,612 shares in the last quarter. Public Employees Retirement System of Ohio bought a new stake in shares of Credicorp during the third quarter valued at approximately $42,794,000. FMR LLC raised its position in shares of Credicorp by 6.1% during the third quarter. FMR LLC now owns 3,446,621 shares of the bank’s stock worth $623,735,000 after purchasing an additional 199,137 shares during the period. Carrhae Capital LLP acquired a new position in shares of Credicorp during the third quarter worth approximately $27,974,000. Finally, TT International Asset Management LTD bought a new position in shares of Credicorp in the 3rd quarter worth $25,081,000. Institutional investors and hedge funds own 89.81% of the company’s stock.
Credicorp Stock Performance
NYSE BAP opened at $184.43 on Thursday. The company has a fifty day moving average price of $186.35 and a 200-day moving average price of $180.46. The firm has a market cap of $14.67 billion, a price-to-earnings ratio of 10.58, a PEG ratio of 0.49 and a beta of 1.12. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.07 and a quick ratio of 1.07. Credicorp Ltd. has a 1 year low of $147.00 and a 1 year high of $200.00.
Analyst Upgrades and Downgrades
BAP has been the topic of several research reports. The Goldman Sachs Group upped their price objective on shares of Credicorp from $143.00 to $160.00 and gave the stock a “sell” rating in a report on Tuesday, October 8th. JPMorgan Chase & Co. upped their target price on shares of Credicorp from $200.00 to $219.00 and gave the stock an “overweight” rating in a report on Tuesday, November 12th. Finally, Bank of America downgraded Credicorp from a “buy” rating to a “neutral” rating and cut their price target for the company from $209.00 to $208.00 in a research note on Monday, December 16th.
Read Our Latest Stock Report on BAP
Credicorp Profile
Credicorp Ltd. provides various financial, insurance, and health services and products primarily in Peru and internationally. It operates through Universal Banking, Insurance and Pensions, Microfinance, and Investment Banking and Equity Management segments. The Universal Banking segment grants various credits and financial instruments to individuals and legal entities; and various deposits and current accounts.
Further Reading
- Five stocks we like better than Credicorp
- How to Find Undervalued Stocks
- Coinbase Gains Momentum on App Store—What It Means for the Stock
- What Are Growth Stocks and Investing in Them
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3 Steel Stocks Soaring After Tariff Announcements
Want to see what other hedge funds are holding BAP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Credicorp Ltd. (NYSE:BAP – Free Report).
Receive News & Ratings for Credicorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Credicorp and related companies with MarketBeat.com's FREE daily email newsletter.